Zacks Investment Research on MSN
Glaukos wins permanent J-code for Epioxa keratoconus therapy
Glaukos GKOS announced that its innovative keratoconus treatment, Epioxa (Epioxa HD / Epioxa), was assigned a permanent HCPCS ...
PROCEPT BioRobotics Corporation announced that its Aquablation therapy has been assigned a Category I Current Procedural Terminology (CPT) code, which will take effect on January 1, 2026. This marks a ...
A 2023 survey by The Gottman Institute, a well-known relationship research institute, 40% of American married couples say they have major marital problems. Fortunately, couples therapy provides a ...
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results